BNTC

Benitec Biopharma Inc.

BNTC.US benitec.com + Research + Basket
CIK 0001808898
Employees 24
Phone 510 780 0819
Fiscal year end June
IPO Aug 18, 2015
Address 3940 Trust Way, Hayward, CA, United States, 94545
8.74
-0.09 (-1.02%)
USD · NASDAQ
52-week range
7.89
16.31
Trading at 10% of the 52-week range
Market Cap
308.07M
P/E Ratio
0.00
Forward P/E
0.00
Book Value
5.14
Div. Yield
N/A
% Institutions
96.04%
% Insiders
0.242%

1 Year

-45.9%

3 Year

+142.1%

10 Year

-97.7%
Description

Benitec Biopharma Inc., a clinical-stage biotechnology company, focuses on the development of novel genetic medicines in the United States. Its Silence and Replace, a DNA-directedRNA interference platform, that combines RNA interference with gene therapy to create medicines which simultaneously facilitate sustained silencing of disease-causing genes and concomitant delivery of wildtype replacement genes following a single administration of the therapeutic construct. The company is developing BB-301, an AAV-based gene therapy designed to silence the expression of the disease-causing gene, which is in phase 1b/2a for the treatment of oculopharyngeal muscular dystrophy related dysphagia. Benitec Biopharma Inc. is headquartered in Hayward, California.

Actions

Add an action for BNTC.US, or sign in to see your action list.

People

▼

Directors & Officers

Name Title Year Born
Ms. Sophie Mukadam Chief Operating Officer 1981
Dr. Michael Graham Head of Discovery & Founding Scientist NA
Dr. Claudia Kloth Ph.D. Senior Vice President of Manufacturing NA

Insider Trading

Open insider trading
Date Insider Name Title Transaction Type Shares Price Value SEC
Dec 29, 2025 Suvretta Capital Management, L N/A Purchase 77.39K $13.44 $1.04M SEC
Dec 26, 2025 Suvretta Capital Management, L N/A Purchase 16.84K $13.10 $220.55K SEC
Dec 23, 2025 Suvretta Capital Management, L N/A Purchase 50.00K $12.85 $642.50K SEC
Dec 22, 2025 Suvretta Capital Management, L N/A Purchase 19.54K $12.08 $236.07K SEC
Dec 19, 2025 Suvretta Capital Management, L N/A Purchase 16.38K $11.48 $188.09K SEC
Dec 18, 2025 Suvretta Capital Management, L N/A Purchase 10.22K $11.24 $114.82K SEC
Nov 07, 2025 Suvretta Capital Management, L N/A Purchase 1.48M $13.50 $20.00M SEC

Shareholders

▼

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
Suvretta Capital Management, LLC 11.55M Jun 30, 2026 33.11% $2.83 0.00%
Nantahala Capital Management, LLC 2.98M Jun 30, 2026 8.53% $0.66 106.95%
HHG PLC 2.88M Mar 31, 2026 8.25% $0.01 -1.21%
Jupiter Topco LLC 2.48M Jun 30, 2026 7.11% $0.01 0.00%
Franklin Templeton Inc 2.41M Jun 30, 2026 6.92% $0.01 1.46%
Adage Capital Partners Gp LLC 2.12M Jun 30, 2026 6.08% $0.04 0.00%
RA Capital Management, LLC 1.85M Jun 30, 2026 5.30% $0.22 0.00%
BlackRock Inc 1.41M Jun 30, 2026 4.03% $0.00 18.67%
Simplify Asset Management Inc. 1.01M Jun 30, 2026 2.88% $0.19 78.85%
Vanguard Capital Management, LLC 954.53K Jun 30, 2026 2.74% $0.00 2.47%
Millennium Management LLC 921.30K Jun 30, 2026 2.64% $0.00 41.29%
Alyeska Investment Group, L.P. 750.00K Jun 30, 2026 2.15% $0.03 0.00%
SILVERARC CAPITAL MANAGEMENT, LLC 679.83K Jun 30, 2026 1.95% $0.95 -5.28%
Balyasny Asset Management LLC 650.50K Jun 30, 2026 1.86% $0.01 -0.51%
Geode Capital Management, LLC 611.74K Jun 30, 2026 1.75% $0.00 16.72%
Ameriprise Financial Inc 401.25K Jun 30, 2026 1.15% $0.00 -1.84%
State Street Corp 377.97K Jun 30, 2026 1.08% $0.00 11.74%
MYDA Advisors LLC 250.00K Jun 30, 2026 0.72% $0.50 11.11%
Schonfeld Strategic Advisors LLC 235.36K Jun 30, 2026 0.67% $0.01 53.65%
Awm Investment Company Inc 187.98K Jun 30, 2026 0.54% $0.22 0.00%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 HBM Healthcare Investments AG Ord 1.19M 3.48% ▲ 0.00% Jun 30, 2026
2 Simplify Health Care ETF 1.00M 2.93% ▲ 0.00% Sep 30, 2026
3 Franklin Biotechnology Discv A(acc)USD 997.48K 2.91% ▲ 0.00% Sep 30, 2026
4 Franklin Biotechnology Discovery A 995.15K 2.91% ▲ 0.00% Sep 30, 2026
5 Vanguard MStar Total Stk Mkt Idx Invest 649.54K 1.90% ▲ 0.00% Sep 30, 2026
6 iShares Russell 2000 ETF 536.22K 1.57% ▼ 1.14% Sep 30, 2026
7 Franklin Small Cap Growth Adv 357.53K 1.04% ▲ 0.00% Sep 30, 2026
8 Fidelity Small Cap Index 233.03K 0.68% ▲ 0.25% Jul 31, 2026
9 iShares Russell 2000 Value ETF 189.19K 0.55% ▲ 0.15% Sep 30, 2026
10 MEDICAL BioHealth EUR Acc 141.96K 0.41% ▼ 27.25% Aug 31, 2026

Financial Highlights

▼
Market Cap: $308.07M
EBITDA: $-51.13M
PEG Ratio: $0.00
Book Value: $5.14
Earnings/Share: $-0.98
Profit Margin: 0.00%
Operating Margin: 0.00%
ROA (TTM): -22.67%
ROE (TTM): -33.21%
Revenue (TTM): $7.00K
Revenue/Share (TTM): $0.00
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 12.50%

Valuation Metrics

Enterprise Value: $128.69M
Trailing P/E: 0.00
Forward P/E: 0.00

Shares Statistics

Shares Outstanding: 34.89M
Shares Float: 19.28M
% Insiders: 0.242%
% Institutions: 96.04%
Shares Short: 1.99M
Shares Short (Prior Month): 2.04M
Short Ratio: 9.77
Short % Float: 9.99%

Stock Price History

▼

1 Year Price History

3 Years Price History

10 Years Price History

Max Price History

Financial Charts

▼
Open balance sheet Open capital intensity Download Financials (Excel)

Revenue, Net Income & Operating Cash Flow (Yearly)

Change % vs Prior Year

Revenue, Net Income & Operating Cash Flow (Quarterly)

Change % vs Prior Quarter

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Income Statement Waterfall

▼
Open full waterfall Open balance sheet
Line Item
Step Type
Value
Revenue
adjust
$0.00
Cost of Goods Sold
adjust
$-481.00K
Gross Profit
subtotal
$-481.00K
SG&A
adjust
$-27.80M
R&D
adjust
$-23.39M
Operating Income
subtotal
$-51.19M
Other / Non-Operating Items
adjust
$5.65M
Net Income
subtotal
$-45.55M

Earnings Per Share (EPS) History

▼

Financial Ratios

▼

📦 Raw API Data (JSON Explorer)

▼

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about BNTC.US!